CLINICAL_TRIALS
research
· 2015-11-05
Clinical Trial Update: First Study of Oral Cysteamine in Cystic Fibrosis [Phase 1, Phase 2]
Summary
The University of Aberdeen conducted a Phase 1/2 clinical trial to evaluate oral cysteamine in individuals with cystic fibrosis, and the study has been complete…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Aberdeen | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: COMPLETED